[{"Assets_0_Q3_USD":675953000.0,"CommonStockSharesOutstanding_0_Q3_shares":101279000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":190553000.0,"StockholdersEquity_0_Q3_USD":267055000.0,"EarningsPerShareBasic_1_Q3_USD":0.39,"EarningsPerShareBasic_3_Q3_USD":1.1,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":101191000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":101134000.0,"Ticker":"INVA","CIK":"1080014","name":"INNOVIVA, INC.","OfficialName":"Innoviva Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1257937389.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191030"}]